Elisabeth Naschberger

15PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Cancer cell biologyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 28, 2026
Fibroblast dynamics in colorectal cancer: stability, plasticity, and novel markers.

|Sep 17, 2025
Automated lesion detection in endoscopic imagery for small animal models - a pilot study.

Thomas Eixelberger, Ralf Hackner, Qi Fang

|Apr 29, 2025
Integrated multimodel analysis of intestinal inflammation exposes key molecular features of preclinical and clinical IBD.

Miguel Gonzalez-Acera, Jay V Patankar, Lena Erkert

|Nov 11, 2024
AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes.

Yongsong Yong, Richard Demmler, Bisan Abdalfatah Zohud

|Mar 13, 2024
Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives.

Anne Jacobsen, Jürgen Siebler, Robert Grützmann

|Oct 20, 2023
Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome.

Elisabeth Naschberger, Maximilian Fuchs, Nicholas Dickel

Pageof 3

Frequent Collaborators

4 joint publications

Michael Stürzl

2 joint publications

Christoph Daniel

2 joint publications

Luitpold V Distel

2 joint publications

Peter Boor